Investigation of Coagulation Parameters in Hereditary Haemorrhagic Telangiectasia
NCT00230659 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2023-09-28
Summary
We will address coagulation parameters in hereditary haemorrhagic telangiectasia (HHT) compared to controls.
Conditions
- Telangiectasia, Hereditary Hemorrhagic
Interventions
- OTHER
-
Blood sample to be taken.
Blood sample to be taken.
Sponsors & Collaborators
-
Hammersmith Hospitals NHS Trust
collaborator OTHER -
Imperial College London
lead OTHER
Principal Investigators
-
Claire Shovlin · Imperial College London
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-08-31
- Primary Completion
- 2007-07-31
- Completion
- 2008-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Longitudinal Cohort of Thrombosis and Hemostasis Diseases
NCT06727669 ·Status: RECRUITING
-
Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs
NCT00230672 ·Status: COMPLETED
-
Thromboelastography (TEG®) and Platelet Function in Patients on Anti-platelet Agents
NCT00901160 ·Status: TERMINATED
-
A Prospective Evaluation of Thromboelastography for Identifying Coagulopathy in Severely Injured Patients
NCT01228058 ·Status: COMPLETED
-
Can Thrombelastography Predict Blood Loss in Patients With Hip Fractures
NCT02297061 ·Status: COMPLETED
-
Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)
NCT01031992 ·Status: COMPLETED ·Phase: PHASE3
-
Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver Transplantation
NCT03942315 ·Status: COMPLETED
-
Association Between Perioperative Platelet Function and Major Adverse Perioperative Events
NCT00901030 ·Status: COMPLETED
-
Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease
NCT06014320 ·Status: UNKNOWN
-
Change in Thrombin Generation Potential and Thromboelastography During the Menstrual Cycle
NCT00178542 ·Status: TERMINATED
-
Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients
NCT01654848 ·Status: COMPLETED
-
Tranexamic Acid for Anaemia Trial
NCT06519422 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Noninferiority Oral Tranexamic Acid vs Intravenous Administration in Total Hip Arthroplasty
NCT04691362 ·Status: COMPLETED ·Phase: PHASE4
-
Thromboelastographic Guide for Blood Products in Cirrhotics
NCT02362178 ·Status: COMPLETED ·Phase: PHASE2
-
Changes in Bleeding and Clotting During the Menstrual Cycle
NCT00480545 ·Status: WITHDRAWN
-
Predictions of Bleeding During Liver Transplantation With Thromboelastometry
NCT02356068 ·Status: COMPLETED
-
Evolution of Thromboelastography During Tranexamic Acid Treatment
NCT03801122 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Rapid Thrombelastography and Conventional Coagulation Testing for Haemostatic Resuscitation in Trauma
NCT01536496 ·Status: COMPLETED ·Phase: NA
-
Association Between Individual Clotting Factor Level Monitoring and the Risk of Bleeding Whilst Physical Active Conditions
NCT04845555 ·Status: UNKNOWN
-
Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery
NCT05783895 ·Status: UNKNOWN
-
The Use of Thrombin Generation Assay in Detection of Central Line Related Thrombosis (CRT) in Critically Ill Patients
NCT06094387 ·Status: RECRUITING
-
A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
NCT00198575 ·Status: UNKNOWN
-
Fresh-Frozen Plasma Infusions to Reduce Risk of Bleeding Related to Invasive Procedures
NCT00233246 ·Status: WITHDRAWN ·Phase: PHASE3
-
Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure
NCT01102790 ·Status: UNKNOWN
-
Thromboelastography (TEG) and Clopidogrel Withdrawal Time in Elderly Patients With Hip Fracture
NCT04165538 ·Status: UNKNOWN ·Phase: NA